These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19053762)

  • 1. Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis.
    Gupte A; Boshoff HI; Wilson DJ; Neres J; Labello NP; Somu RV; Xing C; Barry CE; Aldrich CC
    J Med Chem; 2008 Dec; 51(23):7495-507. PubMed ID: 19053762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine.
    Neres J; Labello NP; Somu RV; Boshoff HI; Wilson DJ; Vannada J; Chen L; Barry CE; Bennett EM; Aldrich CC
    J Med Chem; 2008 Sep; 51(17):5349-70. PubMed ID: 18690677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5'-O-[(N-acyl)sulfamoyl]adenosines as antitubercular agents that inhibit MbtA: an adenylation enzyme required for siderophore biosynthesis of the mycobactins.
    Qiao C; Gupte A; Boshoff HI; Wilson DJ; Bennett EM; Somu RV; Barry CE; Aldrich CC
    J Med Chem; 2007 Nov; 50(24):6080-94. PubMed ID: 17967002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Aryl-8-aza-3-deazaadenosine analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: Nucleoside antibiotics that block siderophore biosynthesis in Mycobacterium tuberculosis.
    Krajczyk A; Zeidler J; Januszczyk P; Dawadi S; Boshoff HI; Barry CE; Ostrowski T; Aldrich CC
    Bioorg Med Chem; 2016 Jul; 24(14):3133-43. PubMed ID: 27265685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.
    Engelhart CA; Aldrich CC
    J Org Chem; 2013 Aug; 78(15):7470-81. PubMed ID: 23805993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic Analyses of the Siderophore Biosynthesis Inhibitor Salicyl-AMS and Analogues as MbtA Inhibitors and Antimycobacterial Agents.
    Bythrow GV; Mohandas P; Guney T; Standke LC; Germain GA; Lu X; Ji C; Levendosky K; Chavadi SS; Tan DS; Quadri LEN
    Biochemistry; 2019 Feb; 58(6):833-847. PubMed ID: 30582694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation and conformational analysis of fluorinated nucleoside antibiotics targeting siderophore biosynthesis.
    Dawadi S; Viswanathan K; Boshoff HI; Barry CE; Aldrich CC
    J Org Chem; 2015 May; 80(10):4835-50. PubMed ID: 25916415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.
    Baran M; Grimes KD; Sibbald PA; Fu P; Boshoff HIM; Wilson DJ; Aldrich CC
    Eur J Med Chem; 2020 Sep; 201():112408. PubMed ID: 32574901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
    Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
    Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl acid adenylating enzymes involved in siderophore biosynthesis: fluorescence polarization assay, ligand specificity, and discovery of non-nucleoside inhibitors via high-throughput screening.
    Neres J; Wilson DJ; Celia L; Beck BJ; Aldrich CC
    Biochemistry; 2008 Nov; 47(45):11735-49. PubMed ID: 18928302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
    Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
    Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
    Jordão AK; Sathler PC; Ferreira VF; Campos VR; de Souza MC; Castro HC; Lannes A; Lourenco A; Rodrigues CR; Bello ML; Lourenco MC; Carvalho GS; Almeida MC; Cunha AC
    Bioorg Med Chem; 2011 Sep; 19(18):5605-11. PubMed ID: 21840219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive models for nucleoside bisubstrate analogs as inhibitors of siderophore biosynthesis in Mycobacterium tuberculosis: pharmacophore mapping and chemometric QSAR study.
    Tawari NR; Degani MS
    Mol Divers; 2011 May; 15(2):435-44. PubMed ID: 20306296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis.
    Somu RV; Boshoff H; Qiao C; Bennett EM; Barry CE; Aldrich CC
    J Med Chem; 2006 Jan; 49(1):31-4. PubMed ID: 16392788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
    Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
    Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a selective activity-based probe for adenylating enzymes: profiling MbtA Involved in siderophore biosynthesis from Mycobacterium tuberculosis.
    Duckworth BP; Wilson DJ; Nelson KM; Boshoff HI; Barry CE; Aldrich CC
    ACS Chem Biol; 2012 Oct; 7(10):1653-8. PubMed ID: 22796950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of beta-ketosulfonamide adenylation inhibitors as potential antitubercular agents.
    Vannada J; Bennett EM; Wilson DJ; Boshoff HI; Barry CE; Aldrich CC
    Org Lett; 2006 Oct; 8(21):4707-10. PubMed ID: 17020283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure-activity relationship of urea derivatives as anti-tuberculosis agents.
    Brown JR; North EJ; Hurdle JG; Morisseau C; Scarborough JS; Sun D; Korduláková J; Scherman MS; Jones V; Grzegorzewicz A; Crew RM; Jackson M; McNeil MR; Lee RE
    Bioorg Med Chem; 2011 Sep; 19(18):5585-95. PubMed ID: 21840723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis.
    Nelson KM; Viswanathan K; Dawadi S; Duckworth BP; Boshoff HI; Barry CE; Aldrich CC
    J Med Chem; 2015 Jul; 58(14):5459-75. PubMed ID: 26110337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.